SME Times News Bureau | 14 Jul, 2018
Commerce
Minister Suresh Prabhu Friday said that India is recognized globally
as one of the key players in the field of generic medicines.
Speaking
at a function organized by the Organization of Pharmaceutical
Producers of India (OPPI), in New Delhi, Prabhu said by
2020 India is likely to be among the top three pharmaceutical markets
by incremental growth and 6th largest market globally in absolute
size.
The
Indian pharmaceuticals market witnessed growth at a compound
annual growth rate (CAGR) of 5.64 per
cent, during 2011 to 2016, with the market increasing from US$ 20.95
billion in 2011 to US$ 27.57 billion in 2016.
The
industry’s revenues are estimated to have grown by 7.4 per cent in
2017.
The
Minister further said that increase in the size of middle class
households coupled with the improvement in medical infrastructure in
the country will influence the growth of the pharmaceuticals sector.
The
minister said that India is the best destination for research in
genomics and their application.
He
called for a balance between the growth of pharma sector and
protection of consumer interests.
Prabhu
said that there are great opportunities in African and Latin American
countries for Indian pharmaceutical industry andIndia has the
potential to become a place for holistic solutions in the healthcare
sector.
He
said that the pharma industry will play a key role in driving India
to become a $ 5 trillion economy.